VIVANZA BIOSCIENCES
Vivanza Biosciences Share Price
Vivanza Biosciences Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Vivanza Biosciences Investment Rating
-
Master Rating:
-
Vivanza Biosciences has an operating revenue of Rs. 12.52 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of 3% needs improvement, ROE of 9% is fair but needs improvement. The company has a debt to equity of 74%, which is bit higher. It is currently FORMING a base in its weekly chart and is trading around 7% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 10 which is a POOR score indicating inconsistency in earnings, a RS Rating of 69 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 96 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
- Indicator
- Jun 2022
- Mar 2022
- Dec 2021
- Sep 2021
- Jun 2021
- Mar 2021
- Oper Rev Qtr Cr
- 2
- 6
- 2
- 2
- 0
- 3
- Operating Expenses Qtr Cr
- 2
- 6
- 1
- 2
- 0
- 3
- Operating Profit Qtr Cr
- 0
- 0
- 0
- 0
- 0
- 0
- Depreciation Qtr Cr
- 0
- 0
- 0
- 0
- 0
- 0
- Interest Qtr Cr
- 0
- 0
- 0
- 0
- 0
- 0
- Tax Qtr Cr
- 0
- 0
- 0
- 0
- 0
- 0
- Net Profit Qtr Cr
- 0
- 0
- 0
- 0
- 0
- 0
Vivanza Biosciences Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 0
- 20 Day
- 180.41
- 50 Day
- 169.69
- 100 Day
- 155.49
- 200 Day
- 133.22
- 20 Day
- 174.89
- 50 Day
- 173.32
- 100 Day
- 147.73
- 200 Day
- 133.01
Vivanza Biosciences Resistance and Support
- First Resistance
- 189
- Second Resistance
- 189
- Third Resistance
- 189
- First Resistance
- 189
- Second Resistance
- 189
- Third Resistance
- 189
- RSI
- 60.29
- MFI
- 98.08
- MACD Single Line
- 3.01
- MACD
- 5.08
Vivanza Biosciences Delivery and Volume
- Period
- NSE + BSE
Volume Avg - NSE + BSE
Delivery Volume Avg - NSE + BSE
Delivery Volume %
- Day
- Week
- 1 Month
- 6 Month
- 30
- 2,967
- 100
Vivanza Biosciences Result Highlights
Vivanza Biosciences Synopsis
BSE-Medical-Diversified
Vivanza Biosciences is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 9.15 Cr. and Equity Capital is Rs. 4.00 Cr. for the Year ended 31/03/2022. Vivanza Biosciences Ltd. is a Public Limited Listed company incorporated on 06/03/1982 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24110GJ1982PLC005057 and registration number is 005057.- Market Cap
- 78
- Sales
- 11
- Shares in Float
- 0.21
- No of funds
- 2
- Yield
- Book Value
- 20.38
- U/D Vol ratio
- LTDebt / Equity
- Alpha
- 0.64
- Beta
- -0.2
Vivanza Biosciences
- Owner Name
- Jun-22
- Mar-22
- Dec-21
- Sep-21
- Promoters
- 47.8%
- 47.8%
- 47.8%
- Financial Institutions/ Banks
- Individual Investors
- 5.67%
- 5.67%
- 6.53%
- Others
- 46.53%
- 46.53%
- 45.67%
Vivanza Biosciences Management
- Name
- Designation
- Mr. Parikh H A
- Director
- Ms. Patel M S
- Director
- Mr. Bhatt G B
- Director
- Mr. Shah S D
- Director
Vivanza Biosciences Forecast
Price Estimates
Vivanza Biosciences Corporate Action
- Date
- Purpose
- Remarks
- 2022-07-21
- Quarterly Results
- 2022-06-21
- Preferential issue of shares
- 2022-06-15
- A.G.M.
- 2022-05-27
- Audited, Quarterly Results & Pref issue
- 2022-02-10
- Quarterly Results
Vivanza Biosciences FAQs
What is Share Price of Vivanza Biosciences ?
Vivanza Biosciences share price is ₹195 As on 09 August, 2022 | 04:46
What is the Market Cap of Vivanza Biosciences ?
The Market Cap of Vivanza Biosciences is ₹78 Cr As on 09 August, 2022 | 04:46
What is the P/E ratio of Vivanza Biosciences ?
The P/E ratio of Vivanza Biosciences is 913.3 As on 09 August, 2022 | 04:46
What is the PB ratio of Vivanza Biosciences ?
The PB ratio of Vivanza Biosciences is 22.3 As on 09 August, 2022 | 04:46